<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>TB R&#38;D Matters Blog &#187; innovations</title>
	<atom:link href="http://www.newtbdrugs.org/blog/tag/innovations/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.newtbdrugs.org/blog</link>
	<description>Working Towards a Faster Cure for Tuberculosis</description>
	<lastBuildDate>Fri, 03 Feb 2012 22:43:04 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.3</generator>
		<item>
		<title>TB R&amp;D Weekly Update:  Tailoring TB Treatment Based on Host Genotype?</title>
		<link>http://www.newtbdrugs.org/blog/2012/02/tb-rd-weekly-update-tailoring-treatment-based-on-host-genotype/</link>
		<comments>http://www.newtbdrugs.org/blog/2012/02/tb-rd-weekly-update-tailoring-treatment-based-on-host-genotype/#comments</comments>
		<pubDate>Fri, 03 Feb 2012 22:40:47 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[Life Cycle of Tuberculosis]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[animal models]]></category>
		<category><![CDATA[host-targeting]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[targets]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[zebra fish]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3466</guid>
		<description><![CDATA[This week we have research out of the Ramakrishnan Laboratory that challenges thinking around tuberculosis treatment and considerations of host genotypes.  Additional links to TB R&#038;D news are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/2012/02/tb-rd-weekly-update-tailoring-treatment-based-on-host-genotype/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>News from the 21st Stop TB Partnership Coordinating Board Meeting, Bangkok</title>
		<link>http://www.newtbdrugs.org/blog/2012/01/news-from-the-21st-stop-tb-partnership-coordinating-board-meeting-bangkok/</link>
		<comments>http://www.newtbdrugs.org/blog/2012/01/news-from-the-21st-stop-tb-partnership-coordinating-board-meeting-bangkok/#comments</comments>
		<pubDate>Tue, 31 Jan 2012 19:37:16 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Action]]></category>
		<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[TAG]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3455</guid>
		<description><![CDATA[he 21st Stop TB Partnership Coordinating Board retreat and meeting officially started in Bangkok, Thailand, on Sunday, January 29th with the official opening ceremony held yesterday January 30th. Included are some exciting news from the meeting courtesy of Mark Harrington, Executive Director of the Treatment Action Group (TAG). ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/2012/01/news-from-the-21st-stop-tb-partnership-coordinating-board-meeting-bangkok/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  SQ109 and PNU Compounds Additive</title>
		<link>http://www.newtbdrugs.org/blog/2012/01/tb-rd-weekly-update-sq109-and-pnu-compounds-additive/</link>
		<comments>http://www.newtbdrugs.org/blog/2012/01/tb-rd-weekly-update-sq109-and-pnu-compounds-additive/#comments</comments>
		<pubDate>Thu, 26 Jan 2012 21:53:44 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[combination therapy]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[new drugs]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3432</guid>
		<description><![CDATA[In this week's article, we look at two drugs in our Global TB Drug Pipeline and how they interact with each other:  SQ109 (class: Ethylenediamines, Sequella) and PNU-100480 (called Sutezolid, class: Oxazolidinone, Pfizer).  Additional links to TB R&#038;D news are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/2012/01/tb-rd-weekly-update-sq109-and-pnu-compounds-additive/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  TDR Tuberculosis Strain Bank</title>
		<link>http://www.newtbdrugs.org/blog/2012/01/tb-rd-weekly-update-tdr-tuberculosis-strain-bank/</link>
		<comments>http://www.newtbdrugs.org/blog/2012/01/tb-rd-weekly-update-tdr-tuberculosis-strain-bank/#comments</comments>
		<pubDate>Fri, 20 Jan 2012 21:02:08 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Early Drug Development]]></category>
		<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[TB Diagnostics]]></category>
		<category><![CDATA[biomarkers]]></category>
		<category><![CDATA[database]]></category>
		<category><![CDATA[diagnostics]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[research tool]]></category>
		<category><![CDATA[resource]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[targets]]></category>
		<category><![CDATA[TDR]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3420</guid>
		<description><![CDATA[This week we highlight an article looking at the TDR Tuberculosis Strain Bank and its utility.  Additional links to TB R&#038;D news are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/2012/01/tb-rd-weekly-update-tdr-tuberculosis-strain-bank/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Kick TB Campaign:  Scoring Big in South Africa and Beyond</title>
		<link>http://www.newtbdrugs.org/blog/2012/01/kick-tb-campaign-scoring-big-in-south-africa-and-beyond/</link>
		<comments>http://www.newtbdrugs.org/blog/2012/01/kick-tb-campaign-scoring-big-in-south-africa-and-beyond/#comments</comments>
		<pubDate>Wed, 18 Jan 2012 19:22:32 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Faces of TB]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3403</guid>
		<description><![CDATA[The Kick TB Campaign is a unique project that uses the World's most popular sport to educate and engage young people in the effort to stop the spread of tuberculosis (TB).  ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/2012/01/kick-tb-campaign-scoring-big-in-south-africa-and-beyond/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update: Tyrosine Kinases as Therapeutic Targets against TB</title>
		<link>http://www.newtbdrugs.org/blog/2011/11/tb-rd-weekly-update-tyrosine-kinases-as-therapeutic-targets-against-tb/</link>
		<comments>http://www.newtbdrugs.org/blog/2011/11/tb-rd-weekly-update-tyrosine-kinases-as-therapeutic-targets-against-tb/#comments</comments>
		<pubDate>Wed, 30 Nov 2011 22:48:19 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[host]]></category>
		<category><![CDATA[host-targeting]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[targets]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3346</guid>
		<description><![CDATA[This week's article looks at host factors that contribute to the ability of Mycobacterium tuberculosis (Mtb) to enter and survive within macrophages.  The authors explore the role of tyrosine kinases (TKs) as a mediator for Mtb and the use of an inhibitor of TKs to act against Mtb and related bacteria.  Additional links to TB R&#038;D news is included]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/2011/11/tb-rd-weekly-update-tyrosine-kinases-as-therapeutic-targets-against-tb/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  Progress in Development of New TB Drugs</title>
		<link>http://www.newtbdrugs.org/blog/2011/11/tb-rd-weekly-update-progress-in-development-of-new-tb-drugs/</link>
		<comments>http://www.newtbdrugs.org/blog/2011/11/tb-rd-weekly-update-progress-in-development-of-new-tb-drugs/#comments</comments>
		<pubDate>Wed, 02 Nov 2011 19:41:50 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[otsuka]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[tb alliance]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3292</guid>
		<description><![CDATA[During last week, the Stop TB Partnership Working Group on New Drugs had a successful annual meeting in Lille, France, in conjunction with the 42nd Union World Conference.  There were quite a few updates to the Global TB Drugs Pipeline showing progress toward the goal of better treatment for TB in all patient populations.  Additional links to TB R&#038;D news are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/2011/11/tb-rd-weekly-update-progress-in-development-of-new-tb-drugs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update: Podcast Interview with Dr. Sanjib Bhakta</title>
		<link>http://www.newtbdrugs.org/blog/2011/10/podcast-interview-with-dr-sanjib-bhakta/</link>
		<comments>http://www.newtbdrugs.org/blog/2011/10/podcast-interview-with-dr-sanjib-bhakta/#comments</comments>
		<pubDate>Wed, 05 Oct 2011 19:21:32 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[WGND Podcast Series]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[podcast]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[screening]]></category>
		<category><![CDATA[targets]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3074</guid>
		<description><![CDATA[This week's interview is with Dr. Sanjib Bhkata who is Head of Mycobacteria Research Laboratory, Microbiology, Department of Biological Sciences, Institute of Structural and Molecular Biology at the Birbeck University of London.  Dr. Bhakta's Laboratory has developed an innovative method for screening compounds that is more efficient and just as accurate as more widely used methods.  Additional links to TB R&#038;D news are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/2011/10/podcast-interview-with-dr-sanjib-bhakta/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  ICAAC and TB Drug Clinical Workshop</title>
		<link>http://www.newtbdrugs.org/blog/2011/09/tb-rd-weekly-update-icaac-and-tb-drug-clinical-workshop/</link>
		<comments>http://www.newtbdrugs.org/blog/2011/09/tb-rd-weekly-update-icaac-and-tb-drug-clinical-workshop/#comments</comments>
		<pubDate>Thu, 29 Sep 2011 20:14:55 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Events]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[animal models]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[conferences and meetings]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[india]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[Lilly]]></category>
		<category><![CDATA[online tools]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3225</guid>
		<description><![CDATA[On September 16, the 4th International Workshop on Clinical Pharmacology of Tuberculosis Drugs was held adjacent to the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) which was held from September 17 to 19.  Between the two meetings, there were many updates related to TB drug development.  Additional links to TB R&#038;D are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/2011/09/tb-rd-weekly-update-icaac-and-tb-drug-clinical-workshop/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  New Target Identified for Pyrazinamide</title>
		<link>http://www.newtbdrugs.org/blog/2011/08/tb-rd-weekly-update-new-target-identified-for-pyrazinamide/</link>
		<comments>http://www.newtbdrugs.org/blog/2011/08/tb-rd-weekly-update-new-target-identified-for-pyrazinamide/#comments</comments>
		<pubDate>Tue, 16 Aug 2011 21:09:36 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[JHU]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[pyrazinamide]]></category>
		<category><![CDATA[pza]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[targets]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3082</guid>
		<description><![CDATA[This week we highlight an article published out of Ying Zhang's laboratory at Johns Hopkins University that puts forth a new model for the mode of action of pyrazinamide (PZA) and as well as suggest trans-translation as a potential target to consider in the development of new drugs for TB.  Additional links to TB R&#038;D news are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/2011/08/tb-rd-weekly-update-new-target-identified-for-pyrazinamide/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

